Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Lems

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 9, 2006
[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis]W F Lems, N A T Hamdy, J C Netelenbos
Clinical and Experimental Rheumatology|October 18, 2012
Do we need guidelines to stop as well as to start biological therapies for rheumatoid arthritis?M van den Broek, W F Lems, C F Allaart
Clinical and Experimental Rheumatology|October 20, 2012
BeSt practice: the success of early-targeted treatment in rheumatoid arthritisM van den Broek, W F Lems, C F Allaart
Annals of the Rheumatic Diseases|September 1, 1995
Cytoplasmic staining, ANA negative status, and ENA testing in rheumatic diseasesW F Lems, D van Schaardenburg, R J van de Stadt
Expert Opinion on Pharmacotherapy|April 9, 2009
Prevention of glucocorticoid-induced osteoporosisM S van Brussel, I E M Bultink, W F Lems
Best Practice & Research. Clinical Rheumatology|September 25, 2019
Secondary fracture prevention: Drug treatment, fall prevention and nutrition requirementsP Geusens, W F Lems, S Bours, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 4, 1995
['Stomach-friendly' NSAIDs: careful optimism?]W F Lems, G P van Berge Henegouwen, J W Bijlsma
Nederlands Tijdschrift Voor Geneeskunde|June 21, 2001
[Safety of specific cyclo-oxygenase 2 inhibitors]W F Lems, M A van de Laar, J W Bijlsma
Clinical and Experimental Rheumatology|May 1, 1995
Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroidsW F Lems, Z N Jahangier, J W Jacobs, et al.
Journal of Dental Research|February 5, 2014
IL-6 alters osteocyte signaling toward osteoblasts but not osteoclastsA D Bakker, R N Kulkarni, J Klein-Nulend, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Nederlands Tijdschrift Voor Geneeskunde|February 9, 2006
[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis]W F Lems, N A T Hamdy, J C Netelenbos
Clinical and Experimental Rheumatology|October 18, 2012
Do we need guidelines to stop as well as to start biological therapies for rheumatoid arthritis?M van den Broek, W F Lems, C F Allaart
Clinical and Experimental Rheumatology|October 20, 2012
BeSt practice: the success of early-targeted treatment in rheumatoid arthritisM van den Broek, W F Lems, C F Allaart
Annals of the Rheumatic Diseases|September 1, 1995
Cytoplasmic staining, ANA negative status, and ENA testing in rheumatic diseasesW F Lems, D van Schaardenburg, R J van de Stadt
Expert Opinion on Pharmacotherapy|April 9, 2009
Prevention of glucocorticoid-induced osteoporosisM S van Brussel, I E M Bultink, W F Lems
Best Practice & Research. Clinical Rheumatology|September 25, 2019
Secondary fracture prevention: Drug treatment, fall prevention and nutrition requirementsP Geusens, W F Lems, S Bours, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 4, 1995
['Stomach-friendly' NSAIDs: careful optimism?]W F Lems, G P van Berge Henegouwen, J W Bijlsma
Nederlands Tijdschrift Voor Geneeskunde|June 21, 2001
[Safety of specific cyclo-oxygenase 2 inhibitors]W F Lems, M A van de Laar, J W Bijlsma
Clinical and Experimental Rheumatology|May 1, 1995
Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroidsW F Lems, Z N Jahangier, J W Jacobs, et al.
Journal of Dental Research|February 5, 2014
IL-6 alters osteocyte signaling toward osteoblasts but not osteoclastsA D Bakker, R N Kulkarni, J Klein-Nulend, et al.
Pageof 18